Interpretation of fine needle aspiration cytology of thyroid: do we need a better classification?

Abstract

Fine needle aspiration cytology technique (FNAC) is a very popular first line investigation for disorders of the thyroid gland. It is a rapid and cost effective technique that can be easily performed in any category of patients. This technique provides useful information for the clinician to plan out the strategy for management of patients.It is critical therefore that the cytopathologist communicate thyroid FNA interpretations to the referring physician in terms that are unambiguous and clinically useful.The currently used classification for thyroid FNAC includes the following categories. Lesions are classified as "Thy 01" when the cellular yield is inadequate. This is often encountered following the aspiration of highly vascular nodules and cystic lesions. One of the main advantages of this cost effective technique is that it can be easily repeated within a short time.When there is unequivocal evidence of a benign condition such as colloid goiter, thyroiditis and hyperplastic nodule the lesion will be classified as "Thy 02". "Thy 03/follicular proliferation" category of the above classification includes a significant number of pathological entities with different clinical outcomes. Conditions that qualify to be included within the "Thy 03" category are hyperplastic nodules with highly cellular smears, florid thyroiditis, neoplastic lesions such as follicular adenoma/carcinoma, hurthle cell tumours (hurthle cell adenoma/carcinoma) and certain types of papillary carcinoma, such as follicular variant of papillary carcinoma when the cytological findings are equivocal. Hence the spectrum of diseases within the "Thy 03" group is comparatively wide.As such, from clinician's point of view a cytological diagnosis of "Thy 03" in the current classification provides little information to plan out the management. Some of the pathological conditions within "Thy 03" do not require surgery and can be managed effectively by medical intervention. Conditions that require surgery need a further qualification as to the precise nature of the lesion. A significant number of "Thy 03" lesions end up with lobectomies as this category does not separate neoplastic from non-neoplastic lesions and benign from malignant conditions. Hence a cytological diagnosis of "Thy 03/follicular proliferation" fails to provide clinically useful information in most of the cases with regard to the management of the patient.Thyroid lesions that have some but not all the features of malignancy are included in "Thy 04" category. The "Thy 05" category includes lesions having unequivocal cytological features of malignancy.Time has arrived to change to a better classification that provides useful information to the clinician enabling him to decide the treatment option. By this means the number of unnecessary thyroid surgery for patients with thyroid disorders can be effectively reduced.The Bethesda system for reporting thyroid cytology (BSRTC) consists of six diagnostic categories. It provides the definitions and morphologic criteria for the different categorie...

Clinicopathological Features and Complications of Thyroid Operations: A Single Centre Experience

“…They are the Bethesda system which has six classes and was proposed by NCI and ''Thy'' classification of BTA which has five results (Thy 1-Thy 5). Bethesda system includes Class III which is Atypia of undetermined significance or follicular lesion of undetermined significance (AUS) [13,14]. The most common lesion in most of the studies were benign and most common was colloid goitre.…”

Bethesda System in the evaluation of thyroid nodules: Review

“…6,7 The introduction of the new system of diagnostics of the thyroid gland was supported by many researchers. 8,9 Fig. 1 presents the recommended diagnostic categories for the Bethesda System and the risk of malignancy for a specific category.…”

Identifying thyroid follicular proliferations that need lobectomy; value of the Bethesda category 4

“…Most of the pathologists in our setting used to favour the pattern of proliferation towards either a non-neoplastic process or a follicular neoplasm. However, there were no accepted uniform criteria to differentiate a follicular ü neoplasm from non-neoplastic lesion in the THY 3 category (5). This was agreed to be a major deficiency in the THY system as further management of these two types of follicular lesions are completely different.…”